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Summary: The euglobulin clot lysis time (ECLT), a traditional measure of plasminogen activation, directly depends on plasma fibrinogen (FBG) level. This fact was neglected in studies concluding that prolonged ECLT in chronic hemodialysis (HD) patients pointed exclusively to impaired fibrinolysis. We studied the relations between ECLT and plasma FBG levels in HD patients in relation to certain hepatic and inflammatory markers. Median (1) . The value is prolonged in patients with acute (2) and chronic (2, 3) renal failure, maintenance hemodialysis (HD) pati~nt~ (4-~~, kidney (7) and heart (8) transplant recipients, and in patients with diabetes (9) and angina pectoris in the European Concerted Action on Thrombosis and Disabilities Angina P~ctc~ris~ (ECAT) Study (10 Fig. 2A However, the ECLT values corrected for the actual FBG levels using the simple formula are not significantly different from those found in healthy subjects. This finding challenges the previously developed paradigm that fibrinolytic activity in the euglobulin fraction is impaired in . HD patients (4) (5) (6) and probably in other populations (2, 3, (7) (8) (9) , including that of the ECAT Pectoris Study (10) .
The euglobulin fraction of plasma contains FBG, plasminogen, active plasmin, and plasminogen activators (11) , and is devoid of potent plasmin inhibitors such as Ot2-antiplasmin and other proteases that are removed with the supernatant (11) . In a study performed in healthy subjects (12) , free plasminogen activator inhibitor-1 remaining in plasma after complexion with tissue plasminogen activator was found to be the key factor determin- 
